SCHEMBL22719425

SCHEMBL22719425

O=C(c1cccnc1-c1ccncn1)N1CCC(Cc2cccc(F)c2F)CC1

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CYP46A1 Q9Y6A2 6/20 0.52
▸ CYP2C9 P11712 3/20 0.45
▸ CYP2C19 P33261 3/20 0.45
▸ MAPK14 Q16539 2/20 0.45
▸ HTR2A P28223 2/20 0.43
▸ HTR2C P28335 2/20 0.43
▸ HPGD P15428 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38
▸ CCR3 P51677 1/20 0.38
▸ CHRM2 P08172 2/20 0.38
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C8 P10632 1/20 0.37
▸ HTR2B P41595 1/20 0.37
▸ GRIN2B Q13224 1/20 0.36
▸ NLN Q9BYT8 2/20 0.36
▸ POLB P06746 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29453783 1.00 CYP46A1 (0.52) CYP46A1CYP2C9CYP2C19MAPK14HTR2A
SCHEMBL29453806 0.84 CYP46A1 (0.56) CYP46A1CYP2C9CYP2C19MAPK14HTR2A
SCHEMBL22719343 0.84 CYP46A1 (0.56) CYP46A1CYP2C9CYP2C19MAPK14HTR2A
SCHEMBL22719247 0.83 CYP46A1 (0.54) CYP46A1CYP2C9CYP2C19MAPK14HTR2A
SCHEMBL29453734 0.83 CYP46A1 (0.54) CYP46A1CYP2C9CYP2C19MAPK14HTR2A
SCHEMBL22719301 0.80 CYP46A1 (0.56) CYP46A1CYP2C9CYP2C19MAPK14ALDH1A1
SCHEMBL29453725 0.80 CYP46A1 (0.56) CYP46A1CYP2C9CYP2C19HPGDKDM4E
SCHEMBL22719250 0.80 CYP46A1 (0.56) CYP46A1CYP2C9CYP2C19HPGDKDM4E
SCHEMBL29453780 0.74 HTR2A (0.51) CYP46A1CYP2C9CYP2C19MAPK14HTR2A
SCHEMBL22719231 0.73 CYP46A1 (0.59) CYP46A1CYP2C9CYP2C19HPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020243027-A1 COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SAGE THERAPEUTICS, INC. (US) 2020-12-03 — — WO disclosed
Send feedback